Medicare Enrolled
Dr. Antony Charles, MD
Hematology & Oncology · Gainesville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Charles from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Charles?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Charles
Dr. Antony Charles is a hematology & oncology specialist in Gainesville, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Charles performed 5,031 Medicare services across 1,023 unique beneficiaries.
Between the years covered by Open Payments, Dr. Charles received a total of $14,142 from 75 pharmaceutical and/or device companies across 843 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Charles is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 21% volume in GA
$14,142 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,031
Medicare services
Top 21% in GA for hematology & oncology
1,023
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~252 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,550 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
322 | $78 | $256 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
245 | $112 | $347 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
171 | $8 | $10 |
| New patient office visit, complex (60-74 min) | 124 | $135 | $496 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
89 | $10 | $36 |
| Manual red blood cell count A laboratory test that manually counts the number of red blood cells in a blood sample. |
65 | $4 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
62 | $52 | $173 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
61 | $13 | $46 |
| Iron level test | 58 | $6 | $22 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
58 | $9 | $30 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
30 | $161 | $670 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
30 | $8 | $27 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
27 | $15 | $51 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
27 | $14 | $50 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
26 | $48 | $524 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
19 | $4 | $15 |
| Stool test for hidden blood (FIT) A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method. |
18 | $16 | $54 |
| Rheumatoid factor level | 17 | $5 | $19 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $69 | $258 |
| Complete x-ray of body bones An x-ray imaging procedure that captures images of the entire skeletal system. |
15 | $52 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,142
Total received (2018-2024)
Avg $2,020/year across 7 years
Top 23% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
843
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,385 (94.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$757 (5.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,610
2023
$2,095
2022
$1,868
2021
$1,060
2020
$1,096
2019
$2,516
2018
$2,896
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$379
PFIZER INC.
$255
AstraZeneca Pharmaceuticals LP
$149
E.R. Squibb & Sons, L.L.C.
$137
Janssen Biotech, Inc.
$135
Novartis Pharmaceuticals Corporation
$125
Eisai Inc.
$119
Exelixis Inc.
$109
ABBVIE INC.
$108
Takeda Pharmaceuticals U.S.A., Inc.
$100
Incyte Corporation
$93
Daiichi Sankyo Inc.
$88
Bayer Healthcare Pharmaceuticals Inc.
$87
Regeneron Healthcare Solutions, Inc.
$65
BeiGene USA, Inc.
$61
SOBI, INC
$54
Merck Sharp & Dohme LLC
$53
Astellas Pharma US Inc
$52
Gilead Sciences, Inc.
$37
GlaxoSmithKline, LLC.
$36
Adaptive Biotechnologies Corporation
$32
Stemline Therapeutics Inc.
$25
GENZYME CORPORATION
$25
ADC Therapeutics America, Inc.
$22
PUMA BIOTECHNOLOGY, INC.
$21
Lilly USA, LLC
$20
Ipsen Biopharmaceuticals, Inc
$20
Mirati Therapeutics, Inc.
$20
Boston Scientific Corporation
$20
Genentech USA, Inc.
$20
SpringWorks Therapeutics, Inc.
$19
Deciphera Pharmaceuticals Inc.
$19
Coherus Biosciences Inc.
$19
SERVIER PHARMACEUTICALS LLC
$19
Alexion Pharmaceuticals, Inc.
$19
Karyopharm Therapeutics Inc.
$18
Agios Pharmaceuticals, Inc.
$16
JAZZ PHARMACEUTICALS INC.
$15
ARRAY BIOPHARMA INC
$1
Top 3 companies account for 30.0% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$1,055
E.R. Squibb & Sons, L.L.C.
$1,026
AstraZeneca Pharmaceuticals LP
$960
Amgen Inc.
$837
Genentech USA, Inc.
$814
Janssen Biotech, Inc.
$737
PFIZER INC.
$669
Novartis Pharmaceuticals Corporation
$632
Merck Sharp & Dohme Corporation
$606
Seagen Inc.
$465
Incyte Corporation
$465
GENZYME CORPORATION
$341
Exelixis Inc.
$321
Takeda Pharmaceuticals U.S.A., Inc.
$312
Daiichi Sankyo Inc.
$300
Bayer HealthCare Pharmaceuticals Inc.
$270
Eisai Inc.
$252
Bayer Healthcare Pharmaceuticals Inc.
$231
JAZZ PHARMACEUTICALS INC.
$231
Gilead Sciences, Inc.
$231
Seattle Genetics, Inc.
$223
Ipsen Biopharmaceuticals, Inc
$218
GlaxoSmithKline, LLC.
$198
BeiGene USA, Inc.
$191
Astellas Pharma US Inc
$182
Lilly USA, LLC
$171
Regeneron Healthcare Solutions, Inc.
$165
ABBVIE INC.
$136
AbbVie Inc.
$132
EISAI INC.
$126
Taiho Oncology, Inc.
$94
EMD Serono, Inc.
$83
ADC Therapeutics America, Inc.
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Merck Sharp & Dohme LLC
$76
Alexion Pharmaceuticals, Inc.
$72
Pharmacyclics LLC, An AbbVie Company
$69
Foundation Medicine, Inc.
$66
Agios Pharmaceuticals, Inc.
$62
SANOFI-AVENTIS U.S. LLC
$60
Stemline Therapeutics Inc.
$60
SOBI, INC
$54
Karyopharm Therapeutics Inc.
$48
Coherus Biosciences Inc.
$47
AbbVie, Inc.
$45
Biocompatibles, Inc.
$44
MorphoSys, US Inc.
$42
PUMA BIOTECHNOLOGY, INC.
$41
Pharmacyclics LLC, an AbbVie Company
$37
G1 Therapeutics, Inc.
$34
Adaptive Biotechnologies Corporation
$32
Verastem, Inc.
$25
Covidien LP
$25
Secura Bio, Inc.
$24
Regeneron Pharmaceuticals, Inc.
$24
Acceleron Pharma, Inc.
$21
Advanced Accelerator Applications
$21
Mirati Therapeutics, Inc.
$20
Boston Scientific Corporation
$20
SpringWorks Therapeutics, Inc.
$19
Deciphera Pharmaceuticals Inc.
$19
SERVIER PHARMACEUTICALS LLC
$19
Jazz Pharmaceuticals Inc.
$18
CTI BioPharma Corp.
$17
AVEO Pharmaceuticals, Inc.
$17
Sobi, Inc
$16
Blueprint Medicines Corporation
$16
Puma Biotechnology, Inc.
$15
Kyowa Kirin, Inc.
$14
Kite Pharma, Inc.
$14
Acrotech Biopharma Inc.
$13
Array BioPharma Inc.
$13
Janssen Scientific Affairs, LLC
$12
TOLMAR Pharmaceuticals, Inc.
$12
ARRAY BIOPHARMA INC
$1
Top 3 companies account for 21.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · Copiktra · Creon · DARZALEX · DOPTELET · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ERBITUX · Enhertu · Erivedge · Erleada · FARYDAK · FASLODEX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · GAVRETO · GAZYVA · GILOTRIF · Gazyva · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · Inrebic · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · LigaSure · Lonsurf · MEKINIST · MONJUVI · MVASI · Morphabond ER · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · Orserdu · PADCEV · PIQRAY · PROMACTA · PROSTATE CANCER - DISEASE · PYRUKYND · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · SANCUSO · SANDOSTATIN · SARCLISA · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SpaceOAR VUE System - 10mL · Stivarga · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · THERASPHERE - BIO · THERASPHERE-BIO · TIBSOVO · TUKYSA · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VELCADE · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vanflyta · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XPOVIO · XTANDI · Xofigo · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
9
Per 100K population
4.3
County median income
$77,430
Nearest hospital
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Charles is a clinical cardiology specialist, with above-average Medicare volume (top 21% in GA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Charles experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Charles performed 3,550 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Charles receive payments from pharmaceutical companies?
Yes. Dr. Charles received a total of $14,142 from 75 companies across 843 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Charles's costs compare to other hematology & oncology specialists in Gainesville?
Dr. Charles's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Charles) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Gainesville
Browse hematology & oncology specialists in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology